Gut Permeability and Microbiota in Parkinson’s Disease: Mechanistic Insights and Experimental Therapeutic Strategies

Globally, Parkinson’s disease (PD) is the neurodegenerative condition with the most rapidly increasing prevalence, and a growing body of evidence associates its pathology with impairments in the gut–brain axis. Traditionally viewed as a disease marked by the loss of dopaminergic neurons, emerging ev...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	International journal of molecular sciences Ročník 26; číslo 19; s. 9593
Hlavní autoři:	Liang, Yicheng, Zhao, Yuhang, Fasano, Alessio, Su, Chien-Wen
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Switzerland MDPI AG 01.10.2025
Témata:	alpha-Synuclein - metabolism Animals Blood-Brain Barrier - metabolism Celiac disease Cytokines Development and progression Fatty acids Gastrointestinal Microbiome - physiology Gluten Gut microbiota Health aspects Homeostasis Humans Hypotheses Inflammation Kinases Metabolites Microbiota (Symbiotic organisms) Neurodegeneration Neurons Parkinson Disease - metabolism Parkinson Disease - microbiology Parkinson Disease - therapy Parkinson's disease Pathogens Pathology Patients Peptides Permeability Proteins Stem cells Toxins Type 2 diabetes Massachusetts gut permeability neuroinflammation Parkinson’s disease (PD) leaky gut therapeutic approaches gut microbiota personalized therapy
ISSN:	1422-0067, 1661-6596, 1422-0067
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Popis
Shrnutí:	Globally, Parkinson’s disease (PD) is the neurodegenerative condition with the most rapidly increasing prevalence, and a growing body of evidence associates its pathology with impairments in the gut–brain axis. Traditionally viewed as a disease marked by the loss of dopaminergic neurons, emerging evidence emphasizes that chronic neuroinflammation is a driver of neurodegeneration, with gut-originating inflammation playing a crucial role. Increased intestinal permeability, often called “leaky gut,” allows harmful substances, toxins, and misfolded α-synuclein into the systemic circulation, potentially exacerbating neuroinflammation and spreading α-synuclein pathology to the brain through the vagus nerve or compromised blood–brain barrier (BBB). This review synthesizes current insights into the relationship between gut health and PD, emphasizing the importance of gut permeability in disrupting intestinal barrier function. This paper highlights innovative therapeutic approaches, particularly personalized therapies involving gut microbiome engineering, as promising strategies for restoring gut integrity and improving neurological outcomes. Modulating specific gut bacteria to enhance the synthesis of certain metabolites, notably short-chain fatty acids (SCFAs), represents a promising strategy for reducing inflammatory responses and decelerating neurodegeneration in Parkinson’s disease.
Bibliografie:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23
ISSN:	1422-0067 1661-6596 1422-0067
DOI:	10.3390/ijms26199593